BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang Y, Xu J, Qiu Z, Guan Y, Zhang X, Zhang X, Chai D, Chen C, Hu Q, Wang W. STK25 enhances hepatocellular carcinoma progression through the STRN/AMPK/ACC1 pathway. Cancer Cell Int 2022;22:4. [PMID: 34986838 DOI: 10.1186/s12935-021-02421-w] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Liu J, Liu B. CircTNPO3 promotes hepatocellular carcinoma progression by sponging miR-199b-5p and regulating STRN expression. Kaohsiung J Med Sci 2023;39:221-33. [PMID: 36524450 DOI: 10.1002/kjm2.12631] [Reference Citation Analysis]
2 Chen KQ, Lei GL, Ke BY, Chen L, Wang ZB, Wang SZ. STK25: a viable therapeutic target for cancer treatments? Anticancer Drugs 2022. [PMID: 36728989 DOI: 10.1097/CAD.0000000000001490] [Reference Citation Analysis]
3 Liu W, Yang HS, Zheng SY, Luo HH, Feng YF, Lei YY. Oxidative stress genes in patients with esophageal squamous cell carcinoma: construction of a novel prognostic signature and characterization of tumor microenvironment infiltration. BMC Bioinformatics 2022;23:406. [PMID: 36180848 DOI: 10.1186/s12859-022-04956-9] [Reference Citation Analysis]
4 Abedi-gaballu F, Kamal Kazemi E, Salehzadeh SA, Mansoori B, Eslami F, Emami A, Dehghan G, Baradaran B, Mansoori B, Cho WC. Metabolic Pathways in Breast Cancer Reprograming: An Insight to Non-Coding RNAs. Cells 2022;11:2973. [DOI: 10.3390/cells11192973] [Reference Citation Analysis]
5 Mahlapuu M, Caputo M, Xia Y, Cansby E. GCKIII kinases in lipotoxicity: Roles in NAFLD and beyond. Hepatol Commun 2022. [PMID: 35641240 DOI: 10.1002/hep4.2013] [Reference Citation Analysis]